Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy

Name: Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy
Published: 2025
License: Public Domain

Ruijin Hospital · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

acute graft versus host disease grade ii-iv, acute graft vs host disease, gecacitinib, ii~iv agvhd, allogeneic hematopoietic stem cell transplantation, ruxolitinib, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy

Related documents